Autonomic Nervous System Drugs Practice Questions

Q: Beta blockers are indicated for all of the following conditions except?

Hypothyroidism. **Explanation** The correct answer is **Hypothyroidism**. Beta-blockers are contraindicated or ineffective here because the condition is characterized by a "hypometabolic" state with bradycardia and decreased sympathetic activity. Adding a beta-blocker would further worsen the bradycardia and potentially lead to heart block or failure. **Why the other options are incorrect:** * **Alcohol Withdrawal:** During withdrawal, there is massive sympathetic overactivity (tachycardia, tremors, hypertension). Beta-blockers (like Propranolol) are used as adjuncts to control these autonomic symptoms. * **Postural Hypotension:** This is a common **side effect** of many drugs, but beta-blockers are generally avoided or used with extreme caution in patients with orthostatic issues. However, in the context of this question, they are specifically **indicated for Hyperthyroidism** (not hypo), making Hypothyroidism the absolute "except" choice. * **Performance Anxiety:** Propranolol is the drug of choice for "stage fright." It blocks the peripheral manifestations of anxiety (palpitations and tremors) without causing sedation. **Clinical Pearls for NEET-PG:** 1. **Hyperthyroidism:** Beta-blockers (Propranolol) are the drug of choice for **Thyroid Storm**. They inhibit the peripheral conversion of T4 to T3 and control tachycardia. 2. **Pheochromocytoma:** Never give a beta-blocker alone; always give an **alpha-blocker first** to prevent a hypertensive crisis caused by unopposed alpha-receptor stimulation. 3. **Specific Beta-blockers:** * **Esmolol:** Shortest acting (used in hypertensive emergencies). * **Nebivolol:** Most cardioselective and produces Nitric Oxide (vasodilation). * **Carvedilol/Labetalol:** Combined alpha and beta-blocking activity.

Q: Which antiglaucoma drug can be used in an asthmatic patient?

Betaxolol. **Explanation:** The primary concern when using beta-blockers for glaucoma in patients with respiratory comorbidities is **bronchoconstriction**. Beta-receptors are divided into $\beta_1$ (predominantly in the heart) and $\beta_2$ (predominantly in the bronchial smooth muscle). **Why Betaxolol is the correct answer:** Betaxolol is a **cardioselective ($\beta_1$ specific) blocker**. Because it lacks significant $\beta_2$ antagonist activity, it does not cause the bronchospasm typically associated with non-selective beta-blockers [1]. This makes it the safest beta-blocker option for patients with **Asthma or Chronic Obstructive Pulmonary Disease (COPD)** [3]. However, it should still be used with caution in severe cases. **Analysis of Incorrect Options:** * **Timolol:** This is a **non-selective beta-blocker** ($\beta_1 + \beta_2$). It is the gold standard for glaucoma but is strictly contraindicated in asthmatics because blocking $\beta_2$ receptors in the lungs leads to life-threatening bronchospasm [3]. * **Propranolol:** This is also a **non-selective beta-blocker** [1]. While it is the prototype of the class, it is not used topically for glaucoma and would be dangerous for an asthmatic patient. * **All:** This is incorrect as Timolol and Propranolol are contraindicated in asthma. **NEET-PG High-Yield Pearls:** * **Mechanism in Glaucoma:** Beta-blockers reduce intraocular pressure (IOP) by **decreasing the production of aqueous humor** from the ciliary body [2]. * **Side Effect Profile:** While Betaxolol is safer for the lungs, it is slightly **less efficacious** in lowering IOP compared to Timolol. * **Drug of Choice:** Currently, **Prostaglandin analogues (e.g., Latanoprost)** have replaced beta-blockers as the first-line treatment for Open-Angle Glaucoma due to better efficacy and fewer systemic side effects.

Q: A patient with glaucoma develops blepharoconjunctivitis after instilling an antiglaucoma drug. Which of the following drugs can be responsible for this adverse reaction?

Timolol. **Explanation:** The correct answer is **Timolol**. **1. Why Timolol is correct:** Timolol is a non-selective beta-blocker and the most commonly used topical agent for glaucoma. **Blepharoconjunctivitis** (inflammation of the eyelids and conjunctiva) is a well-documented local adverse effect of chronic topical beta-blocker therapy. This reaction is often a form of **Type IV hypersensitivity (allergic contact dermatitis)** triggered either by the drug itself or the preservative (commonly Benzalkonium chloride) used in the formulation. Patients typically present with itching, redness, and crusting of the eyelids. **2. Why other options are incorrect:** * **Latanoprost:** Being a Prostaglandin F2α analog, its hallmark side effects include increased iris pigmentation (heterochromia), thickening/darkening of eyelashes (trichomegaly), and conjunctival hyperemia, but it is less commonly associated with classic blepharoconjunctivitis compared to Timolol. * **Dorzolamide:** As a topical Carbonic Anhydrase Inhibitor, its most specific side effects are a bitter taste (dysgeusia) and stinging/burning upon instillation. While it can cause local irritation, Timolol is the classic association for blepharoconjunctivitis in exam vignettes. * **Pilocarpine:** A miotic (cholinergic agonist) primarily associated with "brow ache," pupillary constriction (miosis), and accommodative spasm. **3. High-Yield Clinical Pearls for NEET-PG:** * **Timolol Contraindications:** Always screen for Bronchial Asthma and Bradycardia/Heart block, as systemic absorption through the nasolacrimal duct can occur. * **Preservative-Free Drops:** If a patient develops blepharoconjunctivitis, switching to preservative-free formulations is the first line of management. * **Latanoprost Fact:** It is the drug of choice for Open-Angle Glaucoma (OAG) due to its once-daily dosing and superior efficacy in increasing uveoscleral outflow.

Q: Which one of the following drugs is NOT used in the management of glaucoma?

Donepezil. **Explanation:** The correct answer is **Donepezil**. **1. Why Donepezil is the correct answer:** Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor. Its primary clinical indication is the symptomatic treatment of **Alzheimer’s disease**, as it increases acetylcholine levels in the brain to improve cognitive function. Unlike other cholinesterase inhibitors, it has high selectivity for the central nervous system and is not used topically or systemically for the management of glaucoma. **2. Analysis of incorrect options:** * **Timolol (Option A):** A non-selective beta-blocker and the traditional first-line agent for glaucoma. It works by reducing the production of aqueous humor from the ciliary body. * **Physostigmine (Option B):** A tertiary amine anticholinesterase. When applied topically to the eye, it causes miosis and contraction of the ciliary muscle, which facilitates the drainage of aqueous humor through the trabecular meshwork. * **Dipivefrine (Option C):** A prodrug of epinephrine. It is more lipophilic, allowing better ocular penetration. It reduces intraocular pressure by increasing uveoscleral outflow. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Currently, **Latanoprost** (Prostaglandin analogue) is the DOC for Open-Angle Glaucoma due to high efficacy and once-daily dosing. * **Avoid in Glaucoma:** Mydriatics (like Atropine) are strictly contraindicated in closed-angle glaucoma as they can precipitate an acute attack. * **Donepezil Side Effects:** Common side effects are cholinergic in nature, such as bradycardia, nausea, and diarrhea (SLUDGE syndrome).

Q: All of the following are true regarding muscarinic actions except:

Cardiac muscarinic receptors are predominantly M3 type. ### Explanation The correct answer is **D**, as cardiac muscarinic receptors are predominantly **M2 type**, not M3. **1. Why Option D is the Correct Answer (The False Statement):** Muscarinic receptors are classified into five subtypes (M1–M5). While M3 receptors are widely distributed in smooth muscles and glands, the heart is the primary site for **M2 receptors**. These are G-protein coupled receptors (Gi type) that decrease cAMP, leading to negative chronotropic (rate), dromotropic (conduction), and inotropic (contractility) effects. **2. Analysis of Other Options:** * **Option A (Miosis):** True. Muscarinic stimulation (M3) of the circular muscles (sphincter pupillae) of the iris causes contraction, leading to pupillary constriction (miosis). * **Option B (Detrusor contraction):** True. The bladder contains M3 receptors. Their activation causes the detrusor muscle to contract and the trigone/sphincter to relax, facilitating micturition. * **Option C (Dicyclomine):** True. Dicyclomine is a tertiary amine antimuscarinic agent. It acts as a direct smooth muscle relaxant and is frequently used as an antispasmodic in Irritable Bowel Syndrome (IBS). **3. NEET-PG High-Yield Pearls:** * **M1:** "Neural" (Gastric glands, CNS). * **M2:** "Cardiac" (SA node, AV node, Atria). * **M3:** "Glandular/Smooth Muscle" (Exocrine glands, Bronchi, Bladder, Eye). * **Mnemonic:** Remember **Q-I-Q** for G-protein linkage: M1 (Gq), M2 (Gi), M3 (Gq). * **Clinical Note:** Pilocarpine (M3 agonist) is used in glaucoma, while Atropine (Non-selective antagonist) is used to treat bradycardia by blocking M2 receptors.

Q: All of the following drugs may be used to relieve urinary spasms after urological procedures, EXCEPT:

Tiotropium. The question tests your knowledge of the clinical applications of **Muscarinic Antagonists (Anticholinergics)**. **1. Why Tiotropium is the Correct Answer:** Tiotropium is a long-acting muscarinic antagonist (LAMA) specifically designed for **inhalation** [1]. It has high affinity for M3 receptors in the bronchial smooth muscle, leading to bronchodilation. Because it is administered via inhalation and has poor systemic absorption, it is used exclusively for **COPD and Asthma** [1]. It has no clinical role in treating urinary spasms. **2. Analysis of Incorrect Options (Drugs used for Urinary Spasms):** The bladder detrusor muscle is primarily contracted by **M3 receptors** [2]. To relieve urinary spasms or Overactive Bladder (OAB), we use M3-selective or non-selective muscarinic antagonists [2]: * **Oxybutynin:** A non-selective antagonist that also has direct spasmolytic effects [2]. It is a classic choice for post-surgical bladder spasms but has significant side effects (dry mouth, constipation). * **Tolterodine:** A potent antimuscarinic with relative functional selectivity for the bladder over salivary glands, making it better tolerated than oxybutynin [2]. * **Darifenacin:** A **highly selective M3 antagonist** [2]. By specifically targeting M3 receptors, it reduces detrusor contractions while minimizing M1/M2-mediated side effects (like tachycardia or cognitive impairment). **3. NEET-PG High-Yield Pearls:** * **M3 Selectivity:** Darifenacin and Solifenacin are the most M3-selective agents [2]. * **Mirabegron:** A **Beta-3 ($\beta_3$) agonist** is a newer alternative for OAB/urinary urgency, used when anticholinergics are contraindicated (e.g., in Glaucoma). * **Contraindication:** Avoid all these drugs in patients with **Narrow-Angle Glaucoma** and **Benign Prostatic Hyperplasia (BPH)** with significant obstruction.

Q: The metabolic effects of sympathomimetics are mediated by which receptors?

All beta-adrenergic receptors. **Explanation:** Sympathomimetics exert significant metabolic effects primarily through the activation of **beta-adrenergic receptors ($\beta_1, \beta_2,$ and $\beta_3$)**. While $\alpha$-receptors play a minor role (e.g., $\alpha_1$ can stimulate glycogenolysis), the predominant metabolic surge is mediated by the Beta-family via the Gs-protein/cAMP pathway. * **$\beta_1$ Receptors:** Primarily responsible for **renin release** from juxtaglomerular cells and contributing to lipolysis. * **$\beta_2$ Receptors:** Mediate **glycogenolysis** (liver and muscle) and **gluconeogenesis**, leading to increased blood glucose levels. They also stimulate insulin secretion and promote the uptake of potassium into skeletal muscles (hypokalemia). * **$\beta_3$ Receptors:** Located in adipose tissue, these are the chief mediators of **lipolysis** and thermogenesis. **Analysis of Incorrect Options:** * **Option B (Dopaminergic):** These receptors (D1-D5) are mainly involved in renal vasodilation and CNS modulation, not systemic metabolic regulation. * **Option C (Beta 2):** While $\beta_2$ is crucial for hyperglycemia, it is an incomplete answer because $\beta_1$ and $\beta_3$ are equally essential for the total metabolic profile (lipolysis and renin release). * **Option D (Opioid):** These are involved in analgesia and sedation, having no direct role in sympathomimetic metabolic pathways. **High-Yield NEET-PG Pearls:** * **Hypokalemia:** A classic side effect of $\beta_2$ agonists (like Salbutamol) due to the activation of the Na+/K+ ATPase pump. * **Diabetes Caution:** Non-selective beta-blockers (like Propranolol) can mask the tachycardia of hypoglycemia and delay recovery by inhibiting $\beta_2$-mediated glycogenolysis. * **$\beta_3$ Agonist:** **Mirabegron** is a clinical example used for overactive bladder, but it also stimulates lipolysis.

Q: Which of the following parasympathomimetic drugs is used to treat xerostomia?

Cevimeline. **Explanation:** **Cevimeline** is a synthetic muscarinic agonist with a high affinity for **M3 receptors** located on salivary and lacrimal glands. By stimulating these receptors, it increases secretions, making it a first-line treatment for **xerostomia** (dry mouth), particularly in patients with **Sjögren’s syndrome** or those undergoing head and neck radiation. **Analysis of Options:** * **Bethanechol (A):** While it is a choline ester, it acts preferentially on **M3 receptors in the bladder and GI tract**. It is clinically used to treat post-operative urinary retention and paralytic ileus, not xerostomia. * **Tolterodine (C):** This is a **muscarinic antagonist** (anticholinergic) used to treat overactive bladder. A common side effect of this drug is actually causing xerostomia, not treating it. * **Pirenzepine (D):** This is a selective **M1 receptor antagonist** formerly used to reduce gastric acid secretion in peptic ulcer disease. Being an antagonist, it would decrease rather than increase secretions. **High-Yield NEET-PG Pearls:** * **Pilocarpine** is the other major sialagogue (saliva inducer) used for xerostomia and is also used topically for glaucoma (miotic). * **Sjögren’s Syndrome Triad:** Dry eyes (xerophthalmia), dry mouth (xerostomia), and rheumatoid arthritis. * **Contraindications:** Parasympathomimetics like Cevimeline should be used cautiously in patients with **asthma or COPD** (due to bronchoconstriction) and **acute iritis**.

Question 1

Beta blockers are indicated for all of the following conditions except?

Accepted Answer

Hypothyroidism

Answer

Alcohol withdrawal

Answer

Postural hypotension

Answer

Performance anxiety

Question 2

Which anticholinergic agent is a tertiary amine?

Accepted Answer

Valethamate

Answer

Clidinium

Answer

Glycopyrolate

Answer

Hyoscine

Question 3

Which antiglaucoma drug can be used in an asthmatic patient?

Accepted Answer

Betaxolol

Answer

Timolol

Answer

Propranolol

Answer

All

Question 4

A patient with glaucoma develops blepharoconjunctivitis after instilling an antiglaucoma drug. Which of the following drugs can be responsible for this adverse reaction?

Accepted Answer

Timolol

Answer

Latanoprost

Answer

Dorzolamide

Answer

Pilocarpine

Question 5

Which one of the following drugs is NOT used in the management of glaucoma?

Accepted Answer

Donepezil

Answer

Timolol

Answer

Physostigmine

Answer

Dipivefrine

Question 6

All of the following are true regarding muscarinic actions except:

Accepted Answer

Cardiac muscarinic receptors are predominantly M3 type

Answer

Miosis

Answer

Detrusor muscle contraction

Answer

Dicyclomine is an antimuscarinic drug used for smooth muscle relaxation

Question 7

All of the following drugs may be used to relieve urinary spasms after urological procedures, EXCEPT:

Accepted Answer

Tiotropium

Answer

Darifenacin

Answer

Oxybutynin

Answer

Tolterodine

Question 8

The metabolic effects of sympathomimetics are mediated by which receptors?

Accepted Answer

All beta-adrenergic receptors

Answer

Dopaminergic receptors

Answer

Beta 2 receptors

Answer

Opioid receptors

Question 9

Which of the following drugs is not used in the management of glaucoma?

Accepted Answer

Metoprolol

Answer

Pilocarpine

Answer

Physostigmine

Answer

Timolol

Question 10

Which of the following parasympathomimetic drugs is used to treat xerostomia?

Accepted Answer

Cevimeline

Answer

Bethanechol

Answer

Tolterodine

Answer

Pirenzepine

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?